NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Flex Vascular

Flex Vascular

Private
Plymouth, MinnesotaHealthcare & Life Scienceshttps://www.flexvascular.com/

Last Round

Series C

Oct 29, 2025

Total Funding Raised

$46M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Flex Vascular is a medical device company that develops and markets endovascular devices, including its flagship FLEX Vessel Prep System, to address unmet needs in treating peripheral arterial disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

endovascular devicevessel preparationperipheral arterial diseasePADAV fistulainterventional cardiologyvascular surgerycatheter technologyrevascularizationinterventional radiologymedical device manufacturermedtechinterventional toolsvascular intervention

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Flex Vascular Comps

Public and private peers based on sector, stage, and business model.

Flex Vascular comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Flex Vascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series COct 29, 2025
Seed RoundJan 5, 2024
DebtJan 31, 2023
SeedMay 10, 2018
Series BAug 15, 2017
Series A
Dec 1, 2014

Flex Vascular Investors

Notable investors and investment history

Flex Vascular investors
InvestorRounds
Rocket Venture FundSeries B, Seed, Series A
Ohio Third FrontierAccelerator, Seed
RiverVest Venture PartnersSeries B, Debt
Endeavour VisionSeries C, Series B, Debt
ProMedica InnovationsSeed, Series A
S3 VenturesSeries C
Global Cardiovascular Innovation CenterSeries B, Seed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 29, 2025

    $28M round led by S3 Ventures

  • Jan 31, 2023

    $2M debt round completed.

Flex Vascular Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Flex Vascular Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Flex Vascular's valuation, stock price, and market status.

Firmographic Details

HeadquartersPlymouth, Minnesota
Year Founded2012
Last FundingOct 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.